Filing metadata

Accession number
0001615774-17-005170
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Sep 18, 2017
Reporting period
Sep 18, 2017
Description
Insider transaction

Explore SEC Filings Hub